PLC Systems' angina heart laser:
This article was originally published in Clinica
Japanese regulators have approved for sale PLC Systems' first-generation CO2 heart laser (HL1) device for treating angina. The transmyocardial revascularisation (TMR) product will be distributed in Japan exclusively by Tokyo-based Ktec, which will this year begin the process of establishing the TMR market through hosting educational seminars, attending scientific trade shows and conducting training events. Currently, Ktec has 12 HL1s in Japan, which it purchased in the mid-1990s. Ktec has over 20 sales people in Japan and can sell the HL1 immediately, said Franklin, Massachusetts-based PLC Systems.
You may also be interested in...
Tensions between industry and the European Commission on the issue of health claims for botanical food supplements were aired on the second day of the BAH's High Level Conference on the Future of Medicines, with the EC saying the EU Green Deal is now higher up on its list of priorities for the foreseeable future.
Issues over supply and the use of a skinny label have the potential to take a toll on the market for the fish oil drug icosapent ethyl, one analyst has claimed in the wake of Hikma’s recent generic launch.
The German Bundestag has adopted the Unified Patent Court’s draft ratification bill with the necessary qualified majority.